Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Clinical Trial Phase
|
| gptkbp:canBe |
Active Controls
Historical Controls Placebo Controls |
| gptkbp:cause |
Clinical Guidelines
Regulatory Approval Label Changes Market Authorization |
| gptkbp:dataCollected |
Pharmacokinetics
Pharmacodynamics Efficacy Outcomes Quality of Life Measures Safety Outcomes |
| gptkbp:focusesOn |
Evaluating Treatment Efficacy
Evaluating Treatment Safety |
| gptkbp:goal |
Assess Therapeutic Interventions
Compare Treatments Determine Optimal Dosage Monitor Adverse Effects |
| https://www.w3.org/2000/01/rdf-schema#label |
Therapeutic Studies
|
| gptkbp:mayInclude |
gptkb:Randomized_Controlled_Trials
International National Phase II Phase III Phase IV Pilot Study Observational Study Adaptive Study Blinded Studies Confirmatory Study Equivalence Study Exploratory Study Interventional Study Multi-Center Non-Inferiority Study Non-Randomized Trials Open-Label Studies Pivotal Study Single-Center Superiority Study |
| gptkbp:regulates |
gptkb:Institutional_Review_Boards
Ethics Committees |
| gptkbp:relatedTo |
Clinical Trials
|
| gptkbp:requires |
Ethical Approval
Informed Consent |
| gptkbp:usedIn |
gptkb:Drug_Development
gptkb:Medical_Research |
| gptkbp:bfsParent |
gptkb:Department_of_Social,_Therapeutic_and_Community_Studies
|
| gptkbp:bfsLayer |
7
|